Neuroendoscopy Market – By Product, By Application, By Usability, By Patient, By End Use - Global Forecast, 2025 - 2034

Neuroendoscopy Market Size

The global neuroendoscopy market was valued at USD 168.8 million in 2024. The market is expected to reach from USD 176.8 million in 2025 to USD 290.8 million in 2034, growing at a CAGR of 5.7% during the forecast period. The high market growth can be attributed to the continuous advancements in endoscopic technology, rising healthcare infrastructure and spending, the increasing number of brain tumor cases, and surging demand for minimally invasive surgical procedures, among other contributing factors.
 

The increasing prevalence of neurological conditions, including brain tumors, hydrocephalus, and intracranial cysts, is creating higher demand for neuroendoscopic procedures. For instance, according to the World Health Organization (WHO) in 2023 approximately 50 million people suffer from epilepsy globally and nearly 300,000 people are diagnosed with brain tumors annually. Similarly, as per the CDC report in 2022, roughly 1 in 1,000 infants are born with hydrocephalus. These complex advanced surgical methods lower the risk of complications while treating challenging brain conditions.
 

The growing elderly population, which faces increased risk of neurological disorders, expands the potential patient base. The UN projected that by 2024 people aged 65 and older will make up 10% of the total population. Furthermore, there is heightened burden towards early detection and intervention which promotes the increased use of neuroendoscopes, as evidenced by the NIH plan for funding neuroscience research at USD 3.7 billion in 2023.
 

Furthermore, neuroendoscopy allows the surgical treatment of more intricately located and deeper-seated brain tumors with some minimal external access, which reduces the injurious effect of the surgery on the surrounding tissues. This approach allows for the patient's faster recovery, shorter hospital stay, and overall improved outcome and as such, it is progressively being used more widely.
 

Neuroendoscopy is a highly complex surgical technique that enables profound access to the brain or spinal cords pathologies through minimal forms of invasiveness. With the use of an endoscope, which is a specialized instrument equipped with a bright light and a high-resolution camera, surgeons are capable of maneuvering through small incisions or natural access points to operate on the ventricles of the brain, the base of the brain, and the spine. Compared to traditional surgical methods, this technique has lower risks and shorter recovery periods.
 

Neuroendoscopy Market Trends

The industry is constantly driven by the ever-growing changes in technology in neurosurgery because they provide better precision and safety, resulting in enhanced outcomes of minimally invasive surgeries performed on the brain and spine. All these changes are increasing the usage of neuroendoscopy throughout healthcare systems by changing the way that surgeons deal with complex neurological disorders.
 

• The advanced models of neuroendoscopes use high-definition imaging, 3D viewing capability, and better illumination as an integral part, enabling surgeons to perform intricate navigations of the spinal and cranial regions much more accurately. This improves accuracy in diagnosing medical disorders and in performing surgeries, prompting more and more medical practitioners to utilize these procedures.
   
• Moreover, robotic and artificial intelligence integration into neuroendoscopy is changing the traditional view and expectations of accuracy. With robotic arms, surgeries done by neuroendoscopes are far easier and more precise. Intelligent devices provide real-time cooperative guidance in decision-making, complications are minimized, and outcomes for the patients improve greatly.
   
• The evolution in the design of the endoscope has enabled the development of more flexible, smaller devices or instruments, making it possible to carry out procedures in a much more conservative way with the least amount of trauma to the surrounding tissues. These improvements play an important role in pediatric neurosurgery and difficult regions of anatomy, thereby further increasing the market.
   

Neuroendoscopy Market Analysis

Based on product, the market is classified into rigid neuroendoscopes and flexible neuroendoscopes. The rigid neuroendoscopes segment is further bifurcated into rigid fiberscopes and rigid videoscopes. The rigid neuroendoscopes segment generated the highest revenue of USD 113.1 million in 2024 and is expected to grow during the forecast period.
 

• A rigid neuroendoscope allows for excellent intracranial and spinal structure visualization. This is extremely helpful in performing procedures like ventriculostomies and tumor resections. The mechanisms provided with these bipedic instruments allow maximal manipulation of the gimbal. This is essential for precision surgery.
   
• Such instruments are particularly useful in dealing with cases of hydrocephalus, resection of brain tumors, and other disorders that necessitate surgery on the central nervous system. Their flexibility in use across various peripheral neuroendoscopy procedures makes them essential devices in hospitals and specialized clinics.
   
• Moreover, rigid neuroendoscopes have lower costs associated with maintenance and repairs when compared to flexible neuroendoscopes. As reported in the American Hospital Association (AHA) 2023 survey, hospitals reported a 15% reduction in maintenance costs when using rigid neuroendoscopes compared to flexible variants. The solid structure of rigid neuroendoscopes mitigates a considerable number of mechanical failures which, in turn, decreases the operational costs associated with the device over time. A 2022 NHS study showed that rigid neuroendoscopes had an operational lifespan that was 30% longer than flexible models and required 40% fewer repairs. These cost-saving measures are crucial for facilities operating on a budget, which was the focus of a World Health Organization report that noted a 25% increase in adoption of rigid neuroendoscopes in developing countries. The need for these devices was also spurred by their affordability paired with sharp images, enabling 45% of global market purchasers in 2023 to prefer rigid systems.
   

Based on application, the neuroendoscopy market is classified into transnasal neuroendoscopy, intraventricular neuroendoscopy, and transcranial neuroendoscopy. The intraventricular neuroendoscopy segment held a dominant market share in 2024 and was valued at over USD 86.7 million.
 

• Hydrocephalus affects both pediatric and elderly populations, making it a significant indication for intraventricular neuroendoscopy. According to the National Institute of Neurological Disorders and Stroke (NINDS), estimates that in the U.S., approximately 1 in every 1,000 gives birth to a child with Hydrocephalus. This condition affects more than 700,000 Americans in the year 2023.
   
• Similarly, according to the Hydrocephalus Association, there has been an increase of 32% in the ETV procedures from 2021 to 2023 as compared to the traditional shunt placements. In the year 2024, Medicare data reported a decreased rate of 28% of complications related to shunt procedures in patients who underwent ETV procedures. The rising need for treatment among patients and better clinical results shifts the need for intraventricular neuroendoscopic procedures.
   
• The approach of intraventricular neuroendoscopy is used for third ventriculostomy procedures, which are successful in treating hydrocephalus. Ultrasound imaging of this condition, especially in children and old people, increases its demand. Because of its increasing popularity, this procedure is becoming more frequently utilized.
   
• Furthermore, the development of new techniques, such as structured lighting for high-resolution cameras, as well as panoramic and microscope-mounted navigation devices, has improved the accuracy and safety of intraventricular approaches. Hence, the aforementioned factors are expected to boost the segmental growth in the market.
   

Based on usability, the neuroendoscopy market is classified into reusable neuroendoscopes and disposable neuroendoscopes. The reusable neuroendoscopes segment accounted for USD 146.5 million in 2024 and is anticipated to grow at a CAGR of 5.5% between the 2025 to 2034 period.
 

• Healthcare providers conducting a significant number of procedures stand to benefit from reusable neuroendoscopes. Cost-efficient over time, their long-term use justifies the initial investment. The savings accrued from having to replace the instruments infrequently are appealing from an economic standpoint.
   
• These endoscopy devices support the increasing focus on sustainability within the healthcare sector. As the industry moves towards greener practices, reducing medical waste significantly improves the environmental impact. This is especially useful for regions with strict waste-management regulations, furthering adoption.
   
• The combination of long-term financial savings and reduction of waste makes reusable neuroendoscopes appealing to a majority of healthcare institutions trying to balance economic with ecological concerns.
   

Based on patient, the neuroendoscopy market is classified into adult and pediatric. The adult segment is expected to drive business growth and expand at a CAGR of 5.5%, reaching over USD 239.7 million by 2034.
 

• The number of neuroendoscopic surgeries in adults has increased significantly due to the growing prevalence of neurological disorders. According to the World Health Organization (WHO) 2023 data, there were around 50 million epilepsy sufferers worldwide, and the American Brain Tumor Association reported almost 89,000 new cases of primary brain tumors in 2022.
   
• In addition, the National Institute of Neurological Disorders and Stroke (NINDS) documented that pituitary tumors account for 12-15% of all intracranial tumors in 2023, with about 10,000 new cases diagnosed annually in the U.S. These conditions require advanced imaging and precise surgical techniques achievable through neuroendoscopy.
   
• Most adults, as well as the providers delivering care to them, advocate for the technological shift towards minimally invasive procedures because they result in less recovery time, fewer complications, and shorter hospital stays. These factors are equally important when addressing adult neuropathology, which makes neuroendoscopy a preferred technique.
   

Based on end use, the neuroendoscopy market is segmented into hospitals, ambulatory surgical centers, diagnostic centers, and other end users. The hospitals segment dominated the market in 2024 and is anticipated to reach USD 107.1 million by the end of the forecast period.
 

• Hospitals routinely perform brain and spinal cord surgical procedures, including tumor removal and hydrocephalus treatment. According to the World Health Organization (WHO), neurological disorders affect over 1 billion people globally as of 2022. The American Association of Neurological Surgeons reported that approximately 1.4 million neurosurgical procedures were performed in the America in 2023, a 15% increase from 2021. Additionally, the National Institute of Neurological Disorders and Stroke (NINDS) data shows that hydrocephalus affects nearly 700,000 adults and children in the U.S. in 2024, contributing to the rising demand for neuroendoscopic interventions.
   
• As with any surgery, the accuracy and outcome of the procedure significantly depend on the technology used. For this reason, hospitals are allocating more resources to high-precision devices like high-definition neuroendoscopes. The purchase and implementation of these devices help this segment maintain a significant share of the market.
   

The U.S. neuroendoscopy market was valued at USD 53.4 million and USD 55.4 million in 2021 and 2022, respectively. The market size reached USD 59.9 million in 2024, growing from USD 57.6 million in 2023 and is anticipated to grow at a CAGR of 4.9% between the 2025 to 2034 period.
 

• The U.S. has a substantial patient population with neurological conditions, as evidenced by recent statistics. According to the National Institute of Neurological Disorders and Stroke (NINDS), approximately 1-2 per 1,000 births in the U.S. were affected by hydrocephalus in 2023.
   
• The American Brain Tumor Association stated that there were about 89,810 new primary brain tumors diagnosed in 2022 with an estimated increase to 91,690 cases in 2024. The ageing population is a key driver of this number. The CDC stated that as of 2021, approximately 20.4% of adults aged 65 and older suffer from neurological disorders.
   
• Moreover, the country has efficient reimbursement policies through Medicare, Medicaid, and private payers which reimburse for some minimally invasive neurosurgical procedures, decreasing the patient's financial burden and improving provider adoption. These policies support the direct reimbursement of neuroendoscopy in clinical practice, which in turn, fosters growth of usage in the country.
   

Europe neuroendoscopy market accounted for USD 50.7 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Most Europeans have publicly funded healthcare systems that allow for high-quality neurosurgical care. Such systems facilitate the application of sophisticated medical techniques like neuroendoscopy without imposing great financial burdens on patients. The system guarantees universal access to essential advanced healthcare services. This model facilitates the routine incorporation of neuroendoscopic procedures into hospital practice.
   
• Europe is home to major neuroendoscopy device manufacturers like Karl Storz (Germany) and B. Braun (Germany), as well as global players operating extensively in the region. These companies support their products by offering innovative training to the surgeons and providing sufficient post-market services. Their proximity to Europe enables rapid adoption of new neuroendoscopic technologies. European hospitals often serve as pilot sites for clinical validation and new product launches.
   

France neuroendoscopy market in the Europe is projected to grow remarkably in the coming years.
 

• The increasing prevalence of neurovascular diseases in France, combined with an aging population more susceptible to neurological disorders, drives the demand for neuroendoscopic procedures. According to INSEE (French National Institute of Statistics), the population above the age of 65 years has increased from 13.8 million in 2021 to 14.2 million in 2023, which is 21% of the total population. Additionally, the French Public Health Agency reported that the incidence of stroke rose by 12% from 2021 to 2023, with an estimated 140,000 cases in 2023.
   
• Given the simple execution process and reduced operational complications, France has adopted neuroendoscopy as its default form of performing brain surgeries.
   
• In addition, the development of neuroendoscopy systems is aided by France's powerful position in the Europe regarding healthcare and medical devices policy.
   

The Asia Pacific neuroendoscopy market is anticipated to grow at the highest CAGR of 6.9% during the analysis timeframe.
 

• Asia Pacific countries, particularly China, India, and Southeast Asia, are rapidly upgrading their healthcare infrastructure with advanced surgical technologies. Newly built hospitals and medical colleges are integrating neuroendoscopy systems into their operating suites. This rapid growth establishes strong infrastructure for market expansion with abundant development potential. This, coupled with developing policies on tertiary care hospitals, drives growth.
   
• Countries such as China, India, and Indonesia have observed a rise in the middle-class demographic that is willing to pay for private, quicker healthcare services. Neuroendoscopy is expected to rise in demand as a premium service offered by private hospitals and specialized neurosurgery clinics. This emerging trend will force hospitals and specialty personnel to adopt modern instruments and perform more neuroendoscopy procedures.
   
• Awareness regarding the availability of minimally invasive brain surgeries is increasing across the Asia Pacific region, both among the public and the professional medical community. The faster recovery and lower complication rates offered by neuroendoscopy are being publicized through conferences, social media, and interlocal surgeon groups. The widespread circulation of informed materials promotes adoption of these techniques, contributing to a consistent upward trajectory in the utilization of neuroendoscopic procedures.
   

In the Asia Pacific neuroendoscopy market, Japan is projected to grow remarkably in the coming years.
 

• The increased prevalence of aging-related neurological disorders, such as brain aneurysms, along with the increased focus on minimally invasive procedures, has driven growth in the market.
   
• Japan is also a frontrunner in the development and application of specialized neuroendoscopic techniques, particularly in neuro-oncology and interventional neuroradiology, which increases the need for sophisticated neuroendoscopic devices, thereby leading to the country’s growth in the market.
   

The Brazil neuroendoscopy market is experiencing robust growth in Latin America market.
 

• Brazil’s federal and state governments are progressively investing in modernizing public hospitals under the Unified Health System (SUS).  This also encompasses upgrading surgery centers into more modern equipments, incorporating advanced minimally invasive procedures such as neuroendoscopy. The increase in the number of tertiary care centers in urban and rural areas is improving the access to neurosurgical services, thus increasing the need for neuroendoscopic tools.
   
• The network of private hospitals and insurance-based healthcare in Brazil is expanding, and this is leading to quicker adoption of new premium medical technologies. Private institutions are also procuring neuroendoscopic instruments to boost their clientele among affluent Brazilians and tourists, especially in São Paulo and Rio de Janeiro. Inter-hospital competition is also great in those cities and drives them to innovate with new technologies as well as improve the quality of services provided.
   

Saudi Arabia neuroendoscopy market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• Saudi Arabia's Vision 2030 strategy puts a spotlight on healthcare transformation and new technologies. This program is propelling sophisticated surgical hospitals, including those specializing in neuroendoscopy. With a commitment to national advancement, new and existing hospitals are undergoing major improvements, directly increasing the need for more advanced endoscopic neurosurgical tools.
   
• The Saudi Arabia private healthcare sector is expanding at an unprecedented scale because of privatization policies and expanding insurance coverage. To better serve high-profile patients, private hospitals compete for their business by using new neuroendoscopic surgery techniques. These institutions also work with foreign hospitals and foreign suppliers to ensure their quality.
   

Neuroendoscopy Market Share

The top five companies hold around 30% market share in the global market. These leading players include Karl Storz, B. Braun, adeor Medical, Machida Endoscope, and Advanced Biologics. The market is experiencing growth due to the involvement of various international and national stakeholders. Several factors contribute to shifts in market share, including technological advancements, the granting of new patents, industry mergers and acquisitions, and the development of more efficient and minimally invasive devices. Established firms dominate this market by prioritizing advancements in technology and product quality.
 

The relationship between established companies and emerging biotech startups fosters a competitive environment where both product and price competitiveness are key. Additionally, the adoption of neuroendoscopy devices is supported by collaborations between medical device manufacturers and healthcare institutions, which further enhance marketing efforts. The increasing demand driven by the rising prevalence of neurological disorders and the growing aging population continues to drive market expansion. The market also sees frequent mergers, geographical expansion, and continuous development of new product versions.
 

Neuroendoscopy Market Companies

Prominent players operating in the neuroendoscopy industry include:

• Ackermann
• adeor MEDICAL
• ADVANCED BIOLOGICS
• Advin Health care
• B. Braun
• Chongqing Xishan Science & Technology
• CLARUS MEDICAL
• joimax
• KARL STORZ
• Machida
• SCHINDLER ENDOSKOPIE TECHNOLOGIE
   
• Adeor Medical – The company specializes in developing and manufacturing advanced surgical equipment, with a strong focus on neurosurgery, ENT, gynecology, and vascular surgery. Their commitment to targeted innovation, product safety, and improved efficiency makes them a trusted partner for forward-thinking surgeons.
   
• B. Braun – The firm is known for its advanced medical products and solutions such as surgical sutures and IV containers. They are a leader in providing innovative medical technology that ensures patient safety and quality, making them a trusted partner in healthcare.
   

Neuroendoscopy Industry News

• In April 2025, Yashoda Hospitals, launched the country’s most advanced Center of Excellence for Robotic Neurosurgery and Neuro Endoscopy, marking a historic first in India’s neurosurgical field. The launch coincided with the inaugural ceremony of the “Skull Base Endoscopy” program. This development boosted the neuroendoscopy market by enhancing access to cutting-edge technologies, increasing procedural volumes, and positioning India as a regional hub for advanced neurosurgical care.
   
• In September 2024, Clearmind Biomedical received U.S. FDA 510(k) clearance for its Neuroblade system, a novel neuroendoscopy device designed for minimally invasive procedures with integrated functionalities such as visualization, illumination, irrigation, suction, coagulation, and powered debridement. This regulatory milestone accelerated innovation in the neuroendoscopy market by introducing a multifunctional system that enhances surgical precision and efficiency, thereby supporting broader clinical adoption.
   
• In November 2023, Amrita Hospital launched the Centre for Neuro Endoscopy, known as the Amrita Centre for Neuro Endoscopy (ACNE), to treat patients with neurological and neurosurgical conditions. The centre brought together a multidisciplinary team specializing in skull base, cranial, spine, robotic, and pediatric endoscopy to offer integrated care. This initiative strengthened the neuroendoscopy market by expanding specialized service capacity, enhancing clinical outcomes, and promoting advanced neurosurgical techniques in India.
   

The neuroendoscopy market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product

• Rigid neuroendoscopes
  • Rigid fiberscopes
  • Rigid videoscopes
• Flexible neuroendoscopes

Market, By Application

• Transnasal neuroendoscopy
• Intraventricular neuroendoscopy
• Transcranial neuroendoscopy

Market, By Usability

• Reusable neuroendoscopes
• Disposable neuroendoscopes

Market, By Patient

• Adult
• Pediatric

Market, By End Use

• Hospitals
• Ambulatory surgical centers
• Diagnostic centers
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE